Abstract B063: Efficacy of amivantamab in patients with EGFR-mutated non-small cell lung cancer (NSCLC): A meta-analysis of phase 3 randomized controlled trials
Year: 2025
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Molecular Cancer Therapeutics
Authors: Daniel Thomas. Jones, Riccesha Hattin, Jason Ta, Abbas Hussain, Ramaditya Srinivasmurthy, Rishi Kumar. Nanda, Clinton Lam, Kyaw Zin. Thein
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444347
FWCI:
Cites:
Cited by:
Related to:
